# Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors

> **NCT07536087** · NA · RECRUITING · sponsor: **Institute for Clinical and Experimental Medicine** · enrollment: 50 (estimated)

## Conditions studied

- Endoscopic Ultrasound-Guided Radiofrequency Ablation
- Pancreatic Neuroendocrine Tumors (pNET)
- Pancreatic Cystic Neoplasms

## Interventions

- **PROCEDURE:** Endoscopic ultrasound-guided radiofrequency ablation for pancreatic cystic lesions
- **PROCEDURE:** Endoscopic ultrasound-guided radiofrequency ablation of pancreatic solid lesions

## Key facts

- **NCT ID:** NCT07536087
- **Lead sponsor:** Institute for Clinical and Experimental Medicine
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-11
- **Primary completion:** 2027-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07536087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07536087, "Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07536087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*